Structure Therapeutics Inc Adr (GPCR)

02:13 AM

Structure Therapeutics (NASDAQ:GPCR) Price Target Raised to $120.00 - Defense World

02:13 AM

Dec 13, 2025

Mid Cap Stocks To Watch TodayDecember 8th - MarketBeat

Dec 13, 2025

Dec 13, 2025

Bellevue Group AG Acquires 126,812 Shares of Structure Therapeutics Inc. Sponsored ADR $GPCR - MarketBeat

Dec 13, 2025

Dec 13, 2025

Birchview Capital LP Buys Shares of 36,000 Structure Therapeutics Inc. Sponsored ADR $GPCR - MarketBeat

Dec 13, 2025

Dec 13, 2025

Structure Therapeutics stock price target raised to $120 by Citizens - Investing.com South Africa

Dec 13, 2025

Dec 13, 2025

Structure Therapeutics (NASDAQ:GPCR) Raised to Hold at Wall Street Zen - MarketBeat

Dec 13, 2025

Dec 12, 2025

Structure Therapeutics Inc. (GPCR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Dec 12, 2025

Dec 12, 2025

Federated Hermes Inc. Decreases Stake in Structure Therapeutics Inc. Sponsored ADR $GPCR - MarketBeat

Dec 12, 2025

Dec 11, 2025

Structure Therapeutics closes $747.5 million public offering - Investing.com

Dec 11, 2025

Dec 11, 2025

Pharmaceutical Stocks To Follow TodayDecember 8th - MarketBeat

Dec 11, 2025

Dec 11, 2025

Structure Therapeutics Inc. Sponsored ADR $GPCR Shares Bought by HighVista Strategies LLC - MarketBeat

Dec 11, 2025

Dec 11, 2025

Structure Therapeutics announces $650 million public offering - MSN

Dec 11, 2025

Dec 10, 2025

Structure Therapeutics Announces $650 Million Public Offering - TipRanks

Dec 10, 2025

Dec 10, 2025

Structure Therapeutics’ Leap: What’s Sparking the Surge? - StocksToTrade

Dec 10, 2025

Dec 10, 2025

Structure Therapeutics Shares Surge on Promising Drug Results - TipRanks

Dec 10, 2025

Dec 10, 2025

Structure Therapeutics Inc. (GPCR) Stock: Skyrockets After Positive Obesity Trial Result - Menafn

Dec 10, 2025

Dec 09, 2025

Structure Therapeutics prices upsized $650 million public offering By Investing.com - Investing.com South Africa

Dec 09, 2025

Dec 09, 2025

Structure Therapeutics prices upsized $650 million public offering - Investing.com

Dec 09, 2025

Dec 09, 2025

Structure Therapeutics Announces Pricing of Upsized $650 Million Public Offering of ADSs and Pre-Funded Warrants - GlobeNewswire Inc.

Dec 09, 2025

Dec 09, 2025

Structure Therapeutics (GPCR) Hits 52-Week High on Weight Loss Treatment Trial - Finviz

Dec 09, 2025

Dec 09, 2025

Structure Therapeutics (NASDAQ:GPCR) Sees Strong Trading VolumeWhat's Next? - MarketBeat

Dec 09, 2025

Dec 09, 2025

Discipline and Rules-Based Execution in GPCR Response - news.stocktradersdaily.com

Dec 09, 2025

Dec 09, 2025

Structure Therapeutics (GPCR) Stock Explodes on Obesity Pill Breakthrough: Latest News, Analyst Targets and 2026–2035 Outlook - ts2.tech

Dec 09, 2025

Dec 09, 2025

GPCR Stock Soars 102% on Strong Phase II Obesity Data for Aleniglipron - Yahoo Finance

Dec 09, 2025

Dec 09, 2025

This trade activity should not be overlooked: Structure Therapeutics Inc ADR (GPCR) - setenews.com

Dec 09, 2025

Dec 09, 2025

Structure Therapeutics stock price target raised to $130 by BMO Capital - Investing.com

Dec 09, 2025

Dec 09, 2025

Structure Therapeutics stock price target raised to $99 at Clear Street - Investing.com

Dec 09, 2025

Dec 09, 2025

Biggest Stock Gainers Today in the US (Dec. 9, 2025): Wave Life Sciences, Structure Therapeutics, Confluent and More - ts2.tech

Dec 09, 2025

Dec 08, 2025

Structure Therapeutics Stock Jumps on Trial Results for Weight-Loss Pill - The Wall Street Journal

Dec 08, 2025

Dec 08, 2025

Why Structure Therapeutics Stock Doubled and Then Some on Monday - The Globe and Mail

Dec 08, 2025

Dec 08, 2025

Structure Therapeutics stock hits 52-week high at 45.05 USD By Investing.com - Investing.com Canada

Dec 08, 2025

Dec 08, 2025

Structure Therapeutics Unveils Major Data Release Driving Market Buzz - StocksToTrade

Dec 08, 2025

Dec 08, 2025

Structure Therapeutics stock price target raised to $90 by Stifel - Investing.com

Dec 08, 2025

Dec 08, 2025

Structure Therapeutics stock falls after $500 million share offering By Investing.com - Investing.com India

Dec 08, 2025

Dec 08, 2025

Structure Therapeutics stock falls after $500 million share offering - Investing.com

Dec 08, 2025

Dec 08, 2025

Structure Therapeutics launches $500 million public offering - Investing.com

Dec 08, 2025

Dec 08, 2025

Structure Therapeutics launches $500 million public offering By Investing.com - Investing.com South Africa

Dec 08, 2025

Dec 08, 2025

Structure Therapeutics (NASDAQ: GPCR) plans $500M ADS sale with $75M option - Stock Titan

Dec 08, 2025

Dec 08, 2025

2 companies poised to capitalize on the rise of GLP-1 drugs - Morningstar Australia

Dec 08, 2025

Dec 08, 2025

Structure Therapeutics’ Potential Breakthrough: Market Awaits Data - StocksToTrade

Dec 08, 2025

Dec 08, 2025

Medical Stocks To Watch TodayDecember 8th - MarketBeat

Dec 08, 2025

Dec 08, 2025

Promising Potential of Structure Therapeutics’ Aleniglipron: A Buy Rating Based on Transformative Efficacy and Strategic Innovation - TipRanks

Dec 08, 2025

Dec 08, 2025

Positive Outlook for Structure Therapeutics: Aleniglipron Shows Promising Results in Obesity Treatment - TipRanks

Dec 08, 2025

Dec 08, 2025

Structure Therapeutics (NASDAQ:GPCR) Hits New 1-Year HighStill a Buy? - MarketBeat

Dec 08, 2025

Dec 08, 2025

Structure Phase 2 data for aleniglipron look ‘competitive,’ says Morgan Stanley - TipRanks

Dec 08, 2025

Dec 08, 2025

Structure Therapeutics posts mid-stage weight-loss pill data in line with Eli Lilly rival - Sherwood News

Dec 08, 2025

Dec 08, 2025

Structure Therapeutics stock hits 52-week high at 45.05 USD - Investing.com

Dec 08, 2025

Dec 08, 2025

Structure Therapeutics Announces Positive Clinical Trial Results - TipRanks

Dec 08, 2025

Dec 08, 2025

Structure Therapeutics stock soars after strong weight loss data for oral drug - Investing.com UK

Dec 08, 2025